Sarcoidosis Vasculitis And Diffuse Lung Diseases impact factor, indexing, ranking (2022)


Sarcoidosis

Aim and Scope

Sarcoidosis Vasculitis And Diffuse Lung Diseases is a research journal that publishes research related to Internal Medicine. This journal is published by the Mattioli 1885 SpA. The P-ISSN of this journal is 11240490.

Also, check the other important details below like Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate of Sarcoidosis Vasculitis and Diffuse Lung Diseases.

Sarcoidosis Vasculitis And Diffuse Lung Diseases Ranking

Impact Factor: 1.803
Total Citations: 1320
SJR (SCImago Journal Rank): 0.25
Quartile: Q4

The Impact Factor of Sarcoidosis Vasculitis And Diffuse Lung Diseases is 1.803.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Important Metrics

Journal Title: Sarcoidosis Vasculitis and Diffuse Lung Diseases
Publisher: Mattioli 1885 SpA
P-ISSN: 11240490
Open Access: NO
Subject: Internal Medicine
Citescore: 0.8
SNIP: 0.268
SJR: 0.25
Quartile: 4

Sarcoidosis Vasculitis and Diffuse Lung Diseases Indexing

The Sarcoidosis Vasculitis and Diffuse Lung Diseases is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Sarcoidosis Vasculitis And Diffuse Lung Diseases Impact Factor 2022

The latest impact factor of Sarcoidosis Vasculitis and Diffuse Lung Diseases is 1.803.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.


Sarcoidosis Vasculitis And Diffuse Lung Diseases Quartile

The latest Quartile of Sarcoidosis Vasculitis and Diffuse Lung Diseases is Q4.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Sarcoidosis Vasculitis And Diffuse Lung Diseases?

This journal covers the fields/ categories related to Internal Medicine. If your research field is related to Internal Medicine, then visit the official website of Sarcoidosis Vasculitis and Diffuse Lung Diseases and send your manuscript.

Tips for publishing in Sarcoidosis Vasculitis And Diffuse Lung Diseases:

  • Selection of research problem.
  • Presenting a solution.
  • Designing the paper.
  • Make your manuscript publication worthy.
  • Write an effective results section.
  • Mind your references.

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Even you can Contact the editor of the journal.

Journal Publication Time

Journals usually ask reviewers to provide their reviews within 3-4 weeks. However, few journals have a mechanism to enforce the deadline, which is why it can be hard to predict how long the peer review process will take.

The review time also depends upon the quality of a research paper.


Final Summary

  • The impact factor of Sarcoidosis Vasculitis and Diffuse Lung Diseases is 1.803.
  • It is published by Mattioli 1885 SpA.
  • The journal is indexed in UGC CARE, Scopus, SCIE.
  • The (SJR) SCImago Journal Rank is 0.25.
  • The Sarcoidosis Vasculitis and Diffuse Lung Diseases is a reputed research journal.

Sources:

https://www.scopus.com/sourceid/19085







Similiar Journals


DENTAL AND MEDICAL PROBLEMS
ISSN: 1644-387X
Publisher: WROCLAW MEDICAL UNIV

AMERICAN JOURNAL OF CHINESE MEDICINE
ISSN: 0192-415X
Publisher: WORLD SCIENTIFIC PUBL CO PTE LTD

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
ISSN: 1350-6129
Publisher: TAYLOR & FRANCIS LTD

CURRENT MEDICAL RESEARCH AND OPINION
ISSN: 0300-7995
Publisher: TAYLOR & FRANCIS LTD

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
ISSN: 0014-2972
Publisher: WILEY

INDIAN JOURNAL OF MEDICAL RESEARCH
ISSN: 0971-5916
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONS

JOURNAL OF INVESTIGATIVE MEDICINE
ISSN: 1081-5589
Publisher: BMJ PUBLISHING GROUP

JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION
ISSN: 0030-9982
Publisher: PAKISTAN MEDICAL ASSOC

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
ISSN: 0040-8727
Publisher: TOHOKU UNIV MEDICAL PRESS

TRANSLATIONAL RESEARCH
ISSN: 1931-5244
Publisher: ELSEVIER SCIENCE INC

Top 20 Journals

Credit and Source: Scopus, Clarivate, UGC CARE.